Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
94 Cards in this Set
- Front
- Back
Which type of cholesterol is associated with coronary disease?
|
LDL
|
|
Which type of cholesterol is easier to change levels of pharmacologically?
|
LDL
|
|
What level of LDL is considered at risk?
|
> 100
> 70 for diabetics |
|
Risk factors for heart disease:
|
Age (45/55)
Family history (55/65) HTN Smoking Low HDL (if it's over 60, you lose a risk factor!) |
|
Risks equivalent to having CAD:
|
Diabetes
PAD, AAA |
|
How do statins work?
|
HMG CoA reductase inhibition; increases LDL receptors in the liver
|
|
Uses of statins:
|
Dyslipidemias, prevention of CV events, diabetes
|
|
Non-LDL results of statin use:
|
Regression of atherosclerosis
Promote plaque stability Reduce inflammation Improve endothelial function Decrease thrombogenicity |
|
Adverse effects of statins:
|
Hepatotoxicity
Myopathy/rhabdomyolysis GI effects ** Typically very well tolerated |
|
Interactions with statins:
|
Fibrates, ezetimibe
CYP3A4 inhibitors (PI, azoles, erythromycin) Grapefruit juice |
|
Contraindications of statin use:
|
Most liver diseases, pregnancy
They ARE indicated for nonalcoholic fatty liver |
|
Administration of statins:
|
All oral
Best taken at bedtime or evening |
|
Action of nicotinic acid:
|
Decreases VLDL, which decreases LDL
|
|
Use of nicotinic acid:
|
Lowers triglycerides, increases HDL, lowers LDL
|
|
Adverse effects of nicotinic acid:
|
Flushing occurs with almost all patients!
Hepatotoxic N/V/D, GI upset Hyperglycemia Worsening of gouty arthritis |
|
Administration of nicotinic acid:
|
Take 325mg of aspirin 30 min before dose for flushing
Give at bedtime to decrease GI effects |
|
Examples of fibrates:
|
gemfibrozil (Lopid)
fenofibrate (Tricor) fenofibric acid (Trilipix) |
|
Action of fibrates:
|
complex; has to do with receptors in liver/brown adipose tissue
|
|
Use of fibrates:
|
Reduces triglyceride levels
Little effect on LDL! Increases HDL |
|
Which fibrate is approved for use in combination with a statin?
|
fenofibric acid (Trilipix)
|
|
Adverse effects of fibrates:
|
Liver injury
Increased risk of rhabdomyolysis with statin use Increased risk of gallstones Increased risk of bleeding w/ warfarin |
|
Action of bile-acid sequestrants:
|
Forms an insoluble complex with bile acids in the gut
|
|
Use of bile-acid sequestrants:
|
Lowers LDL in combination with statins or nicotinic acid
|
|
Adverse effects of bile-acid sequestrants:
|
GI effects
Decreases fat-soluble vitamins (ADEK) |
|
Example of bile-acid sequestrant:
|
colesevelam (Welchol) is the drug of choice
|
|
Action of ezetimibe (Zetia):
|
Inhibits cholesterol absorption at brush border
|
|
Adverse effects of ezetimibe (Zetia):
|
Myopathy, LFT increase
|
|
Effect of fish oil supplements:
|
anti-inflammatory
Decreases risk of CHD, CVA |
|
What is Lovaza?
|
Prescription omega-3
|
|
Action of plant stanols:
|
Reduce intestinal absorption of cholesterol
|
|
Statins work best on:
|
LDL
|
|
Tolerability of statins:
|
Good
|
|
Ezetimibe works best on:
|
LDL
|
|
Tolerability of ezetimibe:
|
Good
|
|
Bile acid sequestrants work best on:
|
LDL
|
|
Tolerability of bile acid sequestrants:
|
Poor
|
|
Nicotinic acid works best on:
|
HDL and triglycerides
|
|
Tolerability of nicotinic acid:
|
Reasonable to poor
|
|
Fibrates work best on:
|
Triglycerides
|
|
Tolerability of fibrates:
|
Good
|
|
What is a thrombus platelet plug reinforced with?
|
Fibrin (the end of the coagulation cascade)
|
|
What enzyme digests fibrin and removes clots?
|
Plasmin
|
|
Treatment of arterial thrombus:
|
Anti-platelet medications (or prevention)
|
|
Treatment of venous thrombus:
|
Anticoagulants
|
|
What does thrombin convert?
|
Fibrinogen to fibrin
|
|
Action of anticoagulants:
|
Disrupt the coagulation cascade
|
|
Action of anti-platelets:
|
Inhibit platelet aggregation
|
|
Types of anticoagulants:
|
Heparin, LMWH, warfarin, direct thrombin inibitors
|
|
Types of anti platelets:
|
Aspirin, Plavix (clopidogrel)
|
|
Action of thrombolytics:
|
Lysis of fibrin, dissolution of clots
|
|
Action of heparin:
|
Decreases fibrin formation by promoting action of antithrombin
|
|
Adverse effects of heparin:
|
Hemorrhage
Heparin-induced thrombocytopenia Hypersensitivity |
|
Acute uses of heparin:
|
PE, stroke, DVT, DIC, MI
|
|
Preventitive uses of heparin:
|
Prevention of post-op DVT, cardiac surgery, dialysis
|
|
Safety of heparin in pregnancy:
|
Safe
|
|
Contraindications for heparin:
|
Thrombocytopenia
Hemorrhagic stroke Bleeding, surgery on eye/brain/spinal cord |
|
Use heparin with caution in:
|
Trauma, hemophilia, dissecting aneurysm, PUD, severe HTN, threatened abortion, severe liver/kidney disease
|
|
Lab value to monitor heparin use:
|
aPTT
Normal: 40 sec Target w/ heparin: 60-80 sec |
|
Antidote to heparin:
|
Protamine sulfate
|
|
Administration of heparin:
|
IV (continuous, weight based dosing)
SC (deep injection, rotate sites, avoid umbilicus) |
|
Therapeutic range of heparin:
|
Narrow!!
|
|
Base for dosing of heparin:
|
Weight-based
|
|
In what environments are heparin used?
|
Only inpatient
|
|
Examples of low molecular weight heparin:
|
enoxaparin (Lovenox)
dalteparin (Fragmin) tinzaparin (Innohep) |
|
Action of LMWH:
|
Decreases fibrin formation by enhancing activity of antithrombin
|
|
Uses of LMWH:
|
Prevent/treat DVT
Prevent ischemic complications of unstable angina/MI |
|
Availability of heparin vs. LMWH:
|
LMWH is more available
|
|
Advantages of LMWH:
|
No lab monitoring
Outpatient use Predictable response/fixed dose Greater duration Self administration |
|
Action of direct thrombin inhibitors:
|
Directly inhibits thrombin, duh.
|
|
Only oral anticoagulant in US:
|
Warfarin
|
|
Onset of action of warfarin:
|
Delayed
|
|
Half-life of warfarin:
|
~2 days
|
|
Interactions with warfarin:
|
Many many drug interactions
99% protein bound |
|
Action of warfarin:
|
Blocks synthesis of factors VII, IX, X, and prothrombin by blocking enzyme that converts vitamin K
|
|
Uses of warfarin:
|
Treat/prevent embolic/thrombotic events, prosthetic heart valves, a fib
|
|
Adverse effects of warfarin:
|
Bleeding
|
|
Contraindications for warfarin:
|
Vitamin K deficiency
Liver disease Alcoholism Pregnancy |
|
Goal INR for a fib:
|
2-3
|
|
interactions with warfarin:
|
Heparin
Aspirin Acetaminophen Phenobarbitol Carbamazepine Rifampin Azoles Cimetidine |
|
Lab values to monitor warfarin:
|
PT, INR
Every 2 weeks |
|
Treating warfarin overdose:
|
IV vitamin K
|
|
Dietary teaching with warfarin:
|
Avoid fluctuations in vitamin K (leafy greens, multivit, mayo, canola oil)
|
|
Therapeutic index of warfarin:
|
Low - don't change brands
|
|
Action of dabigatran (Pradaxa):
|
Direct thrombin inhibitor
|
|
Administration of dabigatran (Pradaxa):
|
Strictly BID
wait until INR is <2, then 150mg BID |
|
Downsides to dabigatran (Pradaxa):
|
Cost
Moisture sensitive No antidote (must give FFP) |
|
Use of dabigatran (Pradaxa):
|
Replace warfarin
Only approved for preventing clots in a fib |
|
Use of aspirin:
|
Primary/secondary prevention of MI
Prevention of stroke with TIA hx |
|
Action of aspirin:
|
Inhibits COX, needed by platelets for TXA2
|
|
Use of clopidogrel (Plavix):
|
Secondary prevention of MI, stroke, and other vascular events
Prevent coronary stent stenosis |
|
Action of clopidogrel (Plavix):
|
ADP receptor antagonist
|
|
Tolerance of clopidogrel (Plavix):
|
Well tolerated
|
|
Adverse effects of clopidogrel (Plavix):
|
Bleeding
Abdominal pain Dyspepsia Diarrhea Rash RARELY: TTP |
|
Interactions with clopidogrel (Plavix):
|
PPIs
|